shutterstock_87495637

Drug combinations can boost weight loss, research finds

July 19, 2017
Research and Development biotech, drugs, healthcare, obesity, pharma, pharmaceuticals, weight loss

Researchers at the Perelman School of Medicine at the University of Pennsylvania have found that by combining specific hormone-based drugs …

shutterstock_141299494

UK underperforming in cancer care compared to Europe, according to ABPI report

July 18, 2017
Research and Development ABPI, Cancer, Pancreatic cancer, biotech, heralthcare, lung cancer, ovarian cancer, pharma, pharmaceutical

According to a new report commissioned by the ABPI, the UK is continuing to fall behind in the diagnosis and …

hoiland

Radius bolsters leadership with appointment of Novo Vet

July 18, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, Radius, biotech, drugs, pharma, pharmaceutical

Jesper Høiland has been revealed as the new President and Chief Executive Officer of Radius. The news comes shortly after …

breast_cancer_scan

FDA gives nod to drug that prevents breast cancer recurrence

July 18, 2017
Manufacturing and Production, Sales and Marketing Puma Biotech, biotech, drugs, pharma, pharmaceutical

Puma Biotech has pounced to secure FDA approval for its extended adjuvant treatment for early-stage, HER2-positive breast cancer. The drug, …

Merck to lay off 200 as part of 5-year reorganisation plan

July 18, 2017
Manufacturing and Production Merck, biotech, drugs, healthcare, pharma, pharmaceutical

German drug manufacturer Merck has announced its intention to streamline its manufacturing processes across Europe as part of a five-year …

valeant

Valeant takes huge loss on previous deal to pay down debts

July 18, 2017
Manufacturing and Production, Sales and Marketing Obagi Medical Products, Valeant, biotech, drugs, pharma, pharmaceutical

It is an odd time for Valeant, where selling a part of its business for half of what it paid, …

social-media-550766_640

Pharmafocus wants to hear from you!

July 17, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, biotech, drugs, healthcare, pharma, pharmaceutical

We are always looking for new ways to improve the next issue of Pharmafocus, and now we’re planning a new …

wood-1

GSK completes further high-profile staff acquisition

July 17, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Pfizer, biotech, drugs, pharma, pharmaceutical

Pfizer Senior Vice President of Medicinal Sciences, Tony Wood, has agreed to join GSK, as broken by FierceBiotech. The appointment …

cancer_cells

Research may unlock statins cancer-fighting ability

July 17, 2017
Research and Development, Sales and Marketing Keele University, biotech, drugs, pharma, pharmaceutical, statins

Many previous studies have shown that statins are able to have an impact on cancer cells but the results have …

brexit-referendum-uk-1468255193y2p

What pharma should know about the European Unitary Patent in light of Brexit

July 17, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, UK, biotech, brexit, drugs, healthcare, pharma, pharmaceutical

The departure of the United Kingdom from the European Union, dubbed “Brexit,” has sparked significant economic global uncertainty. Two Brexit-related …

shutterstock_273326141

Pierre Fabre secures Italian distribution rights for Noventure’s Aprotecol

July 17, 2017
Sales and Marketing Aprotecol, Noventure, Pierre Fabre, biotech, colic, drugs, healthcare, pharma, pharmacuetical

Noventure has allied with Pierre Fabre Pharma Italy in a partnership which will see the latter distribute the Spanish start-up’s …

aedes_aegypti_mosquito

20 million mosquitoes to be released to limit population

July 17, 2017
Research and Development, Sales and Marketing Novartis, Verily, biotech, drugs, google, pharma, pharmaceutical

Releasing 20 million mosquitoes does not sound like the right way to go about reducing the overall population; however, the …

FDA refuses approval of Amgen osteoporosis drug

July 17, 2017
Sales and Marketing Amgen, Evenity, Radial, UCB, biotech, drugs, osteoporosis, pharma, pharmaceutical

Amgen and its development partner UCB have announced that the FDA has issued a complete response letter for the biologics …

pascal_soriot

AstraZeneca’s Soriot Teva switch scotched

July 17, 2017
Medical Communications, Sales and Marketing AstraZeneca, Soriot, Teva, biotech, drugs, pharma, pharmaceutical

The rumours, beginning with a report by Israeli newspaper Calcalist, had suggested that Pascal Soriot, CEO of AstraZeneca, appeared to …

UK government announces £86 million funding as tentative AAR step

July 14, 2017
Medical Communications NHS, UK government, biotech, drugs, pharma, pharmaceutical

The UK government has revealed that it will apportion £86 million to help the assessment of new technologies and increase …

brexit_2

What Brexit means for drug regulation

July 14, 2017
Medical Communications, Sales and Marketing biotech, brexit, drugs, healthcare, pharma, pharmaceuticals, regulation

The pharmaceutical sector is one of the most tightly regulated industries, and most of the rules that govern the daily …

document-428331_960_720

Independent panel advise FDA to apply different framework to opioid painkillers

July 14, 2017
Medical Communications FDA, biotech, drugs, opioid, opioid epidemic, pharma, pharmaceutical

Over a year ago, the Obama administration asked the National Academies of Sciences, Engineering, and Medicine to advise them on …

fda2outsideweb

FDA unanimously recommends Mylan and Biocon’s Herceptin biosimilar

July 14, 2017
Manufacturing and Production, Medical Communications, Sales and Marketing Biocon, Herceptin, Mylan, biosimilar, biotech, drugs, healthcare, life sciences, pharma, pharmaceuticals

Mylan and Biocon have revealed that their biosimilar version of Roche and Genentech’s Herceptin (trastuzumab) has received unanimous recommendation from …

The Gateway to Local Adoption Series

Latest content